1Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J]. N Engl Med ,1998,339:1 132.
2Haissaguerre M, Jais P, Shah DC, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci[J]. Circulation, 2000,101:1 409.
3Cappato R, Negroni S, Pecora D. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation[J]. Circulation, 2003, 108:1 599.
4Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation[J]. Circulation, 2002,105:1 077.
5Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia a new anatomic approach for curing atrial fibrillation[J]. Circulation,2000,102: 2 619.
6Pappone C, Manguso F, Vicedomini G,et al.Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach[J]. Circulation,2004,110:3 036.
7Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation[J].Circulation, 2004,109:2 724.
8Oral H, Chugh A, Lemola K, et al. Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: a randomized study[J]. Circulation, 2004,110:2 797.
9Stabile G, Turco P, Rocca VL, et al. Is pulmonary vein isolation necessary for curing atrial fibrillation[J]? Circulation ,2003, 108:657.
10Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation segmental pulmonary vein ostial ablation versus left atrial ablation[J]. Circulation,2003,108:2 355.
9Go AS, Hylek EM, Phillips KA,et al. Prevalence of Diagnosed Atrial Fibrillation in Adults National Implications for Rhythm Management and Stroke Prevention:the Antigoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA ,2001,285:2370
10Atwood JE,Myers JN,Tang XC, et al. Exercise capacity in atrial fibrillation:A substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). American Heart Journal,2007,153:566
